Absolute Oral Bioavailability and Disposition of Deferasirox in Healthy Human Subjects
Absolute Oral Bioavailability and Disposition of Deferasirox in Healthy Human Subjects
About this item
Full title
Author / Creator
Publisher
Oxford, UK: Blackwell Publishing Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Oxford, UK: Blackwell Publishing Ltd
Subjects
More information
Scope and Contents
Contents
Deferasirox is a novel iron chelator formulated as tablets for dispersion (suspension) for once‐a‐day oral administration. The current study evaluated the absolute bioavailability of a single 375‐mg oral dose of deferasirox administered in the form of tablets compared with a 130‐mg intravenous infusion of deferasirox. Since this was a first‐in‐man...
Alternative Titles
Full title
Absolute Oral Bioavailability and Disposition of Deferasirox in Healthy Human Subjects
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_69347023
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_69347023
Other Identifiers
ISSN
0091-2700
E-ISSN
1552-4604
DOI
10.1177/0091270008320316
